# Similasan AG – FDA Inspection, Apr 27, 2026

Source: https://www.keypedia.com/records/fda_inspections/similasan-ag/001769e1-a17a-4bce-b22f-63417f904cc9
Source feed: FDA_Inspections

> FDA inspection 1313406 of Similasan AG, April 27, 2026. 3 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1313406
- Company Name: Similasan AG
- Inspection Date: 2026-04-27
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 3

## Related Documents

- [FDA Inspection 1204144 - 2023-04-04](https://www.keypedia.com/records/fda_inspections/similasan-ag/d03916c3-5fac-4fb3-a45e-302e5b3ce40f)
- FDA Inspection 1028938 - 2017-09-18
- FDA Inspection 937801 - 2015-07-23
- FDA Inspection 851899 - 2013-09-13
- FDA Inspection 727380 - 2011-05-27

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/matthew-b-casale/e78481c6-5fbd-4723-a79c-167176395af8)
- [Saleem A. Akhtar](https://www.keypedia.com/people/saleem-a-akhtar/1ea49212-bea5-4d43-bd0a-cdede4d3b1cf)

Company: https://www.keypedia.com/companies/similasan-ag/c9b97bc2-9876-49bf-9b34-57cf8c5717e8

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
